Kevin Atchison
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
- Biological Psychiatry top 10%
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Cancer therapeutics and mechanisms 3
-
- Alzheimer's disease research and treatments 7
- Co-authors
- David Riddell (8 shared papers)Hua Zhou (2 shared papers)Menelas N. Pangalos (4 shared papers)Suzan Aschmies (3 shared papers)George E. Davis (1 shared paper)DDW Cornelison (1 shared paper)Kevin E. Fisher (1 shared paper)Ashley L. Siegel (1 shared paper)
- Journals
- The Journal of Antibiotics (4 papers)Alzheimer s & Dementia (3 papers)Journal of Neuroscience (2 papers)Frontiers in Pharmacology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Kevin Atchison
23 papers receiving 908 citations
Peers
Comparison fields: 5 of 89
- Physiology 441
- Biological Psychiatry 35
- Neurology 84
- Pharmacology 166
- Cellular and Molecular Neuroscience 188
Countries citing papers authored by Kevin Atchison
This map shows the geographic impact of Kevin Atchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Atchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Atchison more than expected).
Fields of papers citing papers by Kevin Atchison
This network shows the impact of papers produced by Kevin Atchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Atchison. The network helps show where Kevin Atchison may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Atchison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 280 | |
| 2 | 2005 | 184 | |
| 3 | 2009 | 133 | |
| 4 | 2012 | 70 | |
| 5 | 2016 | 63 | |
| 6 | 2014 | 43 | |
| 7 | 1994 | 39 | |
| 8 | 1999 | 27 | |
| 9 | 1996 | 20 | |
| 10 | 2011 | 19 | |
| 11 | Synthesis of podophyllotoxin congeners as potential DNA topoisomerase II inhibitors. | 1995 | 11 |
| 12 | 2013 | 11 | |
| 13 | 1994 | 7 | |
| 14 | 1995 | 5 | |
| 15 | 1996 | 4 | |
| 16 | 1998 | 4 | |
| 17 | 1997 | 4 | |
| 18 | 2012 | 3 | |
| 19 | 2008 | 3 | |
| 20 | 2020 | 2 |
About Kevin Atchison
Kevin Atchison is a scholar working on Molecular Biology, Physiology, Organic Chemistry, Pharmacology and Cellular and Molecular Neuroscience, having authored 23 papers that have together received 936 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Synthesis and biological activity (3 papers), Cancer therapeutics and mechanisms (3 papers), Memory and Neural Mechanisms (3 papers), Organic and Inorganic Chemical Reactions (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Physiology (441 citations), Biological Psychiatry (35 citations), Neurology (84 citations), Pharmacology (166 citations) and Cellular and Molecular Neuroscience (188 citations). Kevin Atchison has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include David Riddell, Hua Zhou, Menelas N. Pangalos, Suzan Aschmies, George E. Davis, DDW Cornelison, Kevin E. Fisher, Ashley L. Siegel, Margaret M. Zaleska and Peter J. Atkinson. Their work appears in journals such as The Journal of Antibiotics, Alzheimer s & Dementia, Journal of Neuroscience, Frontiers in Pharmacology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.